Activated met signalling in the developing mouse heart leads to cardiac disease

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Leo, Christian ^a   Sala, Valentina ^a   Morello, Mara ^b   Chiribiri, Amedeo ^b,d   Riess, Ilan ^a   Mancardi, Daniele ^a   Schiaffino, Stefano ^c   Ponzetto, Carola ^a   Crepaldi, Tiziana ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TROPONIN I; TROPONIN T; MUSCLE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; GENE ACTIVATION; HEART DEVELOPMENT; HEART DISEASE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRENATAL PERIOD; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTOLIC DYSFUNCTION; UPREGULATION; ANIMAL; ANTIBODY SPECIFICITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HEART MUSCLE; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; CONNEXIN 43; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEART; HEART DISEASES; HEPATOCYTE GROWTH FACTOR; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 79951801313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014675     Document Type: Article

References (37)

1. Porrello ER, Widdop RE, Delbridge LMD, (2008) Early Origins of Cardiac Hypertrophy: Does Cardiomyocyte Attrition Programme for Pathological 'Catch-Up' Growth of the Heart? Clin Exp Pharmacol Physiol 35: 1358-1364.
2. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ, (1989) Weight in infancy and death from ischaemic heart disease. Lancet 2: 577-580.
3. Li FQ, Wang XJ, Capasso JM, Gerdes AM, (1996) Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746.
4. Schiaffino S, Gorza L, Ausoni S, (1993) Troponin Isoform Switching in the Developing Heart and its Functional Consequences. Trends Cardiovasc Med 3: 12-17.
5. Siedner S, Kruger M, Schroeter M, Metzler D, Roell W, et al. (2003) Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol-London 548: 493-505.
6. Lyons GE, Schiaffino S, Sassoon D, Barton P, Buckingham M, (1990) Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol 111: 2427-2436.
7. Hirschy A, Schatzmann F, Ehler E, Perriard JC, (2006) Establishment of cardiac cytoarchitecture in the developing mouse heart. Dev Biol 289: 430-441.
8. Boccaccio C, Comoglio PM, (2006) Opinion- Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 6: 637-645.
9. Moumen A, Ieraci A, Patane S, Sole C, Comella JX, et al. (2007) Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3K-Akt-dependent manner. Hepatology 45: 1210-1217.
10. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, et al. (2000) Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106: 1511-1519.
11. Ueda H, Nakamura T, Matsumoto K, Sawa Y, Matsuda H, et al. (2001) A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc Res 51: 41-50.
12. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, et al. (2005) Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97: 663-673.
13. Rappolee DA, Iyer A, Patel Y, (1996) Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis. Circ Res 78: 1028-1036.
14. Song W, Majka SM, McGuire PG, (1999) Hepatocyte growth factor expression in the developing myocardium: evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression. Dev Dyn 214: 92-100.
15. Zammit PS, Kelly RG, Franco D, Brown N, Moorman AF, et al. (2000) Suppression of atrial myosin gene expression occurs independently in the left and right ventricles of the developing mouse heart. Dev Dyn 217: 75-85.
16. Giacobini P, Messina A, Wray S, Giampietro C, Crepaldi T, et al. (2007) Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration. J Neurosci 27: 431-445.
17. Crepaldi T, Bersani F, Scuoppo C, Accornero P, Prunotto C, et al. (2007) Conditional activation of MET in differentiated skeletal muscle induces atrophy. J Biol Chem 282: 6812-6822.
18. Yu Z, Redfern CS, Fishman GI, (1996) Conditional transgene expression in the heart. Circ Res 79: 691-697.
19. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, et al. (1991) Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 69: 1476-1486.
20. Naitoh K, Ichikawa Y, Miura T, Nakamura Y, Miki T, et al. (2006) MitoK(ATP) channel activation suppresses gap junction permeability in the ischemic myocardium by an ERK-dependent mechanism. Cardiovasc Res 70: 374-383.
21. Feigenbaum H, Armstrong WF, Ryan T, (2005) Evaluation of systolic and diastolic function of the left ventricle Feigenbaum's Echocardiography. Lippincott Williams & Wilkins.
22. Peschard P, Park M, (2007) From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 26: 1276-1285.
23. Redfern CH, Coward P, Degtyarev MY, Lee EK, Kwa AT, et al. (1999) Conditional expression and signaling of a specifically designed G(i)-coupled receptor in transgenic mice. Nat Biotechnol 17: 165-169.
24. Maillet M, Purcell NH, Sargent MA, York AJ, Bueno OF, et al. (2008) DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility. J Biol Chem 283: 31246-31255.
25. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KDR, et al. (2001) Myocardial Akt activation and gender- Increased nuclear activity in females versus males. Circ Res 88: 1020-1027.
26. Doble BW, Dang XT, Ping PP, Fandrich RR, Nickel BE, et al. (2004) Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci 117: 507-514.
27. Kardami E, Doble BW, (1998) Cardiomyocyte gap junctions: A target of growth-promoting signaling. Trends Cardiovasc Med 8: 180-187.
28. Ikejima K, Watanabe S, Kitamura T, Hirose M, Miyazaki A, et al. (1995) Hepatocyte growth factor inhibits intercellular communication via gap junctions in rat hepatocytes. Biochem Biophys Res Commun 214: 440-446.
29. Moorby CD, Stoker M, Gherardi E, (1995) Hgf/Sf Inhibits Junctional Communication. Exp Cell Res 219: 657-663.
30. Severs NJ, Bruce AF, Dupont E, Rothery S, (2008) Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 80: 9-19.
31. Kaprielian RR, Gunning M, Dupont E, Sheppard MN, Rothery SM, et al. (1998) Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 97: 651-660.
32. Gutstein DE, Morley GE, Vaidya D, Liu F, Chen FL, et al. (2001) Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 104: 1194-1199.
33. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, et al. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3: 347-361.
34. Lei L, Mason S, Liu DG, Huang Y, Marks C, et al. (2008) Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Mol Cell Biol 28: 3790-3803.
35. Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K, et al. (2002) Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 40: 47-53.
36. Ferreira-Cornwell MC, Luo Y, Narula N, Lenox JM, Lieberman M, et al. (2002) Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci 115: 1623-1634.
37. Gutstein DE, Liu FY, Meyers MB, Choo A, Fishman GI, (2003) The organization of adherens junctions and desmosomes at the cardiac intercalated disc is independent of gap junctions. J Cell Sci 116: 875-885.